- Home
- MAN vs APGE Comparison
MAN vs APGE Comparison
Compare MAN & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAN
- APGE
- Stock Information
- Founded
- MAN 1948
- APGE 2022
- Country
- MAN United States
- APGE United States
- Employees
- MAN N/A
- APGE N/A
- Industry
- MAN Professional Services
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAN Consumer Discretionary
- APGE Health Care
- Exchange
- MAN Nasdaq
- APGE Nasdaq
- Market Cap
- MAN 2.1B
- APGE 2.0B
- IPO Year
- MAN 1988
- APGE 2023
- Fundamental
- Price
- MAN $41.27
- APGE $37.87
- Analyst Decision
- MAN Hold
- APGE Strong Buy
- Analyst Count
- MAN 5
- APGE 5
- Target Price
- MAN $48.40
- APGE $95.40
- AVG Volume (30 Days)
- MAN 702.3K
- APGE 431.7K
- Earning Date
- MAN 10-16-2025
- APGE 08-11-2025
- Dividend Yield
- MAN 5.47%
- APGE N/A
- EPS Growth
- MAN N/A
- APGE N/A
- EPS
- MAN N/A
- APGE N/A
- Revenue
- MAN $17,539,500,000.00
- APGE N/A
- Revenue This Year
- MAN $0.74
- APGE N/A
- Revenue Next Year
- MAN $3.40
- APGE N/A
- P/E Ratio
- MAN N/A
- APGE N/A
- Revenue Growth
- MAN N/A
- APGE N/A
- 52 Week Low
- MAN $37.97
- APGE $26.20
- 52 Week High
- MAN $75.57
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- MAN 48.04
- APGE 51.33
- Support Level
- MAN $40.41
- APGE $35.68
- Resistance Level
- MAN $42.52
- APGE $38.75
- Average True Range (ATR)
- MAN 1.35
- APGE 1.59
- MACD
- MAN -0.05
- APGE 0.19
- Stochastic Oscillator
- MAN 20.43
- APGE 69.51
About MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.